Research Article
Prognostic Significance of CIP2A in Esophagogastric Junction Adenocarcinoma: A Study of 65 Patients and a Meta-Analysis
Table 1
Correlations of CIP2A expression with clinicopathologic parameters in EGJA.
| Variable | No. of patients | CIP2A expression | a | Low (%) | High (%) |
| Total cases | 65 | 23 (35.4) | 42 (64.6) | | Age (years) | | | | 0.140 | ≤65 | 24 | 11 (16.9) | 13 (20.0) | | >65 | 41 | 12 (18.5) | 29 (44.6) | | Gender | | | | 0.606 | Male | 51 | 18 (27.7) | 33 (50.8) | | Female | 14 | 5 (7.7) | 9 (13.8) | | Grade | | | | 0.357 | Low (I-II) | 39 | 15 (23.1) | 24 (36.9) | | High (III-IV) | 26 | 8 (12.3) | 18 (27.7) | | TNM stage | | | | 0.402 | Early (I-II) | 20 | 8 (12.3) | 12 (18.5) | | Late (III-IV) | 45 | 15 (23.1) | 30 (46.2) | | Lymph metastasis | | | | 0.402 | No | 20 | 8 (12.3) | 12 (18.5) | | Yes | 45 | 15 (23.1) | 30 (46.2) | | Metastasis | | | | 0.414 | No | 63 | 23 (35.4) | 40 (61.5) | | Yes | 2 | 0 (0.0) | 2 (3.1) | |
|
|
aFisher’s exact test.
|